Drug recall D-0767-2022
Product
Meclizine Hydrochloride Tablets USP, 12.5 mg, packaged in a case of 24 bottles (100-count bottle), Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD, 21801, NDC 59746-122-06
Reason for recall
Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Lots and codes
Lot # 22P0036, Exp 12/2024
Recall details
- Recalling firm
- Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD
- Quantity
- 12,174 bottles
- Distribution
- Product was distributed in Arkansas, Florida, North Carolina, South Carolina and Ohio.
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 8, 2022
- Terminated
- November 15, 2022
Related products
- Meclizine Hydrochloride – drug information
- NDC 59746-122 Meclizine Hydrochloride · Meclizine Hydrochloride 12.5 mg/1 · Jubilant Cadista Pharmacuticals Inc.
- NDC 59746-121 Meclizine Hydrochloride · Meclizine Hydrochloride 25 mg/1 · Jubilant Cadista Pharmacuticals Inc.